msrc.umn.edu

Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. MS can be hard to track and measure and affects each patient differently. The M-Health Fairview Multiple Sclerosis Division utilizes a comprehensive, leading-edge approach to diagnose, evaluate, and treat patients living with demyelinating and autoimmune disorders of the brain and spinal cord such as MS.

Our program is affiliated with the National MS Society and works closely with the MS Foundation and the Consortium of MS Centers (CMSC) in order to provide educational programs that meet the needs of patients and their families.

Recent research at the University of Minnesota, has opened novel monitoring and treatment opportunities for MS patients. Access to 10.5 and 7.0T fMRI at the Center for Magnetic Resonance Research offers M-Health Fairview clinicians the most up-to-date imaging facilities to track the progression of the disease and quickly identify developing abnormalities. Further, developments relating to stem cell infusions, the transplantation of hematopoietic stem cells, can significantly improve disease outcomes and prolong the remission state. Our St. Louis Park infusion center was the second in the nation, and first in Minnesota, to provide this treatment.

This research requires the participation of those living with MS to take part in clinical trials undertaken by MSRC scientists. This page is dedicated to examining that research and demonstrating how you can take part in advancing treatments for those living with multiple sclerosis.